Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric McDade

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Biometrics|June 22, 2026
Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's diseaseZhichen Xu, Jimin Ding, Xiaogang Su, et al.
Alzheimer Disease and Associated Disorders|December 29, 2015
Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging CohortVishwajit L Nimgaonkar, Robert H Yolken, Tianxiu Wang, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's diseaseFuhai Li, Abdallah Eteleeb, William Buchser, et al.
Statistics in Medicine|May 10, 2024
Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methodsGuoqiao Wang, Whedy Wang, Brian Mangal, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot StudyBeth E Snitz, Oscar L Lopez, Eric McDade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseJohannes Levin, Jonathan Vöglein, Yakeel T Quiroz, et al.
Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.
Molecular Neurodegeneration|February 6, 2026
Targeting tau in Alzheimer's Disease: rationale, approach and challengesAram Aslanyan, Martha S Foiani, Tatiana A Giovannucci, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last Visit for Alzheimer's Disease Clinical TrialsGuoqiao Wang, Tianle Chen, John O'Gorman, et al.
Frontiers in Aging Neuroscience|October 14, 2022
Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's diseaseFuhai Li, Abdallah M Eteleeb, William Buchser, et al.
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Biometrics|June 22, 2026
Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's diseaseZhichen Xu, Jimin Ding, Xiaogang Su, et al.
Alzheimer Disease and Associated Disorders|December 29, 2015
Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging CohortVishwajit L Nimgaonkar, Robert H Yolken, Tianxiu Wang, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's diseaseFuhai Li, Abdallah Eteleeb, William Buchser, et al.
Statistics in Medicine|May 10, 2024
Novel non-linear models for clinical trial analysis with longitudinal data: A tutorial using SAS for both frequentist and Bayesian methodsGuoqiao Wang, Whedy Wang, Brian Mangal, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Amyloid-β Imaging in Older Adults Presenting to a Memory Clinic with Subjective Cognitive Decline: A Pilot StudyBeth E Snitz, Oscar L Lopez, Eric McDade, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 25, 2022
Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer diseaseJohannes Levin, Jonathan Vöglein, Yakeel T Quiroz, et al.
Alzheimer'S Research & Therapy|December 21, 2022
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept studyEric McDade, Jeffrey L Cummings, Shobha Dhadda, et al.
Molecular Neurodegeneration|February 6, 2026
Targeting tau in Alzheimer's Disease: rationale, approach and challengesAram Aslanyan, Martha S Foiani, Tatiana A Giovannucci, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Harnessing Greater Statistical Power: Comprehensive Evaluation of Disease Modifying Treatment Effects Across All or Multiple Post-Baseline Visits Compared to the Last Visit for Alzheimer's Disease Clinical TrialsGuoqiao Wang, Tianle Chen, John O'Gorman, et al.
Frontiers in Aging Neuroscience|October 14, 2022
Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's diseaseFuhai Li, Abdallah M Eteleeb, William Buchser, et al.
Pageof 20